Sunday, January 18, 2026 | 05:03 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Jenburkt Pharmaceuticals standalone net profit rises 46.65% in the September 2016 quarter

Capital Market

Sales rise 13.85% to Rs 28.61 crore

Net profit of Jenburkt Pharmaceuticals rose 46.65% to Rs 5.03 crore in the quarter ended September 2016 as against Rs 3.43 crore during the previous quarter ended September 2015. Sales rose 13.85% to Rs 28.61 crore in the quarter ended September 2016 as against Rs 25.13 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales28.6125.13 14 OPM %24.2620.89 -PBDT7.455.78 29 PBT7.005.31 32 NP5.033.43 47

Powered by Capital Market - Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 22 2016 | 6:51 PM IST

Explore News